SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Degenhardt F) "

Sökning: WFRF:(Degenhardt F)

  • Resultat 491-500 av 528
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
491.
  • Arnau-Soler, A, et al. (författare)
  • Genome-wide by environment interaction studies of depressive symptoms and psychosocial stress in UK Biobank and Generation Scotland
  • 2019
  • Ingår i: Translational psychiatry. - : Springer Science and Business Media LLC. - 2158-3188. ; 9:1, s. 14-
  • Tidskriftsartikel (refereegranskat)abstract
    • Stress is associated with poorer physical and mental health. To improve our understanding of this link, we performed genome-wide association studies (GWAS) of depressive symptoms and genome-wide by environment interaction studies (GWEIS) of depressive symptoms and stressful life events (SLE) in two UK population-based cohorts (Generation Scotland and UK Biobank). No SNP was individually significant in either GWAS, but gene-based tests identified six genes associated with depressive symptoms in UK Biobank (DCC, ACSS3, DRD2, STAG1, FOXP2 and KYNU; p < 2.77 × 10−6). Two SNPs with genome-wide significant GxE effects were identified by GWEIS in Generation Scotland: rs12789145 (53-kb downstream PIWIL4; p = 4.95 × 10−9; total SLE) and rs17070072 (intronic to ZCCHC2; p = 1.46 × 10−8; dependent SLE). A third locus upstream CYLC2 (rs12000047 and rs12005200, p < 2.00 × 10−8; dependent SLE) when the joint effect of the SNP main and GxE effects was considered. GWEIS gene-based tests identified: MTNR1B with GxE effect with dependent SLE in Generation Scotland; and PHF2 with the joint effect in UK Biobank (p < 2.77 × 10−6). Polygenic risk scores (PRSs) analyses incorporating GxE effects improved the prediction of depressive symptom scores, when using weights derived from either the UK Biobank GWAS of depressive symptoms (p = 0.01) or the PGC GWAS of major depressive disorder (p = 5.91 × 10−3). Using an independent sample, PRS derived using GWEIS GxE effects provided evidence of shared aetiologies between depressive symptoms and schizotypal personality, heart disease and COPD. Further such studies are required and may result in improved treatments for depression and other stress-related conditions.
  •  
492.
  •  
493.
  • Bigdeli, TB, et al. (författare)
  • Genetic effects influencing risk for major depressive disorder in China and Europe
  • 2017
  • Ingår i: Translational psychiatry. - : Springer Science and Business Media LLC. - 2158-3188. ; 7:3, s. e1074-
  • Tidskriftsartikel (refereegranskat)abstract
    • Major depressive disorder (MDD) is a common, complex psychiatric disorder and a leading cause of disability worldwide. Despite twin studies indicating its modest heritability (~30–40%), extensive heterogeneity and a complex genetic architecture have complicated efforts to detect associated genetic risk variants. We combined single-nucleotide polymorphism (SNP) summary statistics from the CONVERGE and PGC studies of MDD, representing 10 502 Chinese (5282 cases and 5220 controls) and 18 663 European (9447 cases and 9215 controls) subjects. We determined the fraction of SNPs displaying consistent directions of effect, assessed the significance of polygenic risk scores and estimated the genetic correlation of MDD across ancestries. Subsequent trans-ancestry meta-analyses combined SNP-level evidence of association. Sign tests and polygenic score profiling weakly support an overlap of SNP effects between East Asian and European populations. We estimated the trans-ancestry genetic correlation of lifetime MDD as 0.33; female-only and recurrent MDD yielded estimates of 0.40 and 0.41, respectively. Common variants downstream of GPHN achieved genome-wide significance by Bayesian trans-ancestry meta-analysis (rs9323497; log10 Bayes Factor=8.08) but failed to replicate in an independent European sample (P=0.911). Gene-set enrichment analyses indicate enrichment of genes involved in neuronal development and axonal trafficking. We successfully demonstrate a partially shared polygenic basis of MDD in East Asian and European populations. Taken together, these findings support a complex etiology for MDD and possible population differences in predisposing genetic factors, with important implications for future genetic studies.
  •  
494.
  •  
495.
  •  
496.
  •  
497.
  • Czamara, D, et al. (författare)
  • Integrated analysis of environmental and genetic influences on cord blood DNA methylation in new-borns
  • 2019
  • Ingår i: Nature communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 10:1, s. 2548-
  • Tidskriftsartikel (refereegranskat)abstract
    • Epigenetic processes, including DNA methylation (DNAm), are among the mechanisms allowing integration of genetic and environmental factors to shape cellular function. While many studies have investigated either environmental or genetic contributions to DNAm, few have assessed their integrated effects. Here we examine the relative contributions of prenatal environmental factors and genotype on DNA methylation in neonatal blood at variably methylated regions (VMRs) in 4 independent cohorts (overall n = 2365). We use Akaike’s information criterion to test which factors best explain variability of methylation in the cohort-specific VMRs: several prenatal environmental factors (E), genotypes in cis (G), or their additive (G + E) or interaction (GxE) effects. Genetic and environmental factors in combination best explain DNAm at the majority of VMRs. The CpGs best explained by either G, G + E or GxE are functionally distinct. The enrichment of genetic variants from GxE models in GWAS for complex disorders supports their importance for disease risk.
  •  
498.
  •  
499.
  •  
500.
  • Gorski, Mathias, et al. (författare)
  • Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline
  • 2021
  • Ingår i: Kidney International. - : Elsevier. - 0085-2538 .- 1523-1755. ; 99:4, s. 926-939
  • Tidskriftsartikel (refereegranskat)abstract
    • Rapid decline of glomerular filtration rate estimated from creatinine (eGFRcrea) is associated with severe clinical endpoints. In contrast to cross-sectionally assessed eGFRcrea, the genetic basis for rapid eGFRcrea decline is largely unknown. To help define this, we meta-analyzed 42 genome-wide association studies from the Chronic Kidney Diseases Genetics Consortium and United Kingdom Biobank to identify genetic loci for rapid eGFRcrea decline. Two definitions of eGFRcrea decline were used: 3 mL/min/1.73m2/year or more ("Rapid3"; encompassing 34,874 cases, 107,090 controls) and eGFRcrea decline 25% or more and eGFRcrea under 60 mL/min/1.73m2 at follow-up among those with eGFRcrea 60 mL/min/1.73m2 or more at baseline ("CKDi25"; encompassing 19,901 cases, 175,244 controls). Seven independent variants were identified across six loci for Rapid3 and/or CKDi25: consisting of five variants at four loci with genome-wide significance (near UMOD-PDILT (2), PRKAG2, WDR72, OR2S2) and two variants among 265 known eGFRcrea variants (near GATM, LARP4B). All these loci were novel for Rapid3 and/or CKDi25 and our bioinformatic follow-up prioritized variants and genes underneath these loci. The OR2S2 locus is novel for any eGFRcrea trait including interesting candidates. For the five genome-wide significant lead variants, we found supporting effects for annual change in blood urea nitrogen or cystatin-based eGFR, but not for GATM or LARP4B. Individuals at high compared to those at low genetic risk (8-14 vs 0-5 adverse alleles) had a 1.20-fold increased risk of acute kidney injury (95% confidence interval 1.08-1.33). Thus, our identified loci for rapid kidney function decline may help prioritize therapeutic targets and identify mechanisms and individuals at risk for sustained deterioration of kidney function.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 491-500 av 528
Typ av publikation
tidskriftsartikel (396)
konferensbidrag (3)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (511)
övrigt vetenskapligt/konstnärligt (9)
Författare/redaktör
Meyer, J. (401)
Evans, H. (400)
Kehoe, R. (399)
Piegaia, R. (399)
Borissov, G. (398)
Chakraborty, D. (398)
visa fler...
Cheu, E. (398)
Cooke, M. (398)
Fox, H. (398)
Garcia, C. (398)
Haas, A. (398)
Kupco, A. (398)
Pleier, M. -A. (398)
Quadt, A. (398)
Sawyer, L. (398)
Schwartzman, A. (398)
Vachon, B. (398)
Abbott, B. (397)
Brandt, A. (397)
Brock, R. (397)
Burdin, S. (397)
Jakobs, K. (397)
Khanov, A. (397)
Lokajicek, M. (397)
Mitrevski, J. (397)
Owen, M. (397)
Qian, J. (397)
Rijssenbeek, M. (397)
Schaile, D. (397)
Schwienhorst, R. (397)
Shabalina, E. (397)
Shamim, M. (397)
Snyder, S. (397)
Spurlock, B. (397)
Stark, J. (397)
De, K. (396)
Duflot, L. (396)
Sosebee, M. (396)
Strauss, M. (396)
Watts, G. (396)
Wermes, N. (396)
White, A. (396)
Andeen, T. (395)
Fiedler, F. (395)
Hohlfeld, M. (395)
Protopopescu, S. (395)
Rizatdinova, F. (395)
Simak, V. (395)
Tsybychev, D. (395)
Wicke, D. (395)
visa färre...
Lärosäte
Uppsala universitet (288)
Kungliga Tekniska Högskolan (254)
Stockholms universitet (217)
Lunds universitet (198)
Karolinska Institutet (118)
Göteborgs universitet (49)
visa fler...
Högskolan Dalarna (32)
Umeå universitet (17)
Chalmers tekniska högskola (8)
Mittuniversitetet (7)
Södertörns högskola (3)
Örebro universitet (2)
visa färre...
Språk
Engelska (528)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (262)
Medicin och hälsovetenskap (80)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy